Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 May 2025 - 13:15

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/omjjara

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters